Answers are grounded in this paper and cite their sources.
Kidney involvement largely determines prognosis in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), yet serum creatinine, proteinuria and haematuria cannot reliably separate active vasculitis from chronic damage or flare mimics, and kidney biopsy is invasive and rarely repeated. Unlike recent systematic reviews, which assessed a few soluble serum and urinary markers of overall disease activity, this structured narrative review covers the full range of urinary markers of renal involvement, organises them by clinical question and grades the evidence for each. A PubMed search identified 77 clinical studies. Urinary soluble CD163 is the most extensively validated marker; an accredited assay identified renal flare with an area under the curve of 0.95 in a prospective multicentre cohort. Urinary CD4+ T cells discriminate active glomerulonephritis and, in one prospective study, predicted six-month renal relapse with high specificity but modest sensitivity. Persistent haematuria after induction is the most consistently replicated predictor of renal relapse, whereas persistent proteinuria or albuminuria mainly predicts kidney failure. Urinary MCP-1 supports within-patient monitoring, and complement fragments and markers of tubular injury and fibrosis mainly add prognostic information. No urinary marker is yet ready for routine use, and the validation needed is outlined.
No takes yet. Share an insight, caveat, or question.
Mohrag et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: